Plan Nacional De Preparación Y Respuesta Ante La Intensificación De La Influenza Estacional / Pandemia De Influenza

Objectives

Mexico’s National Preparedness and Response Plan for an Influenza Pandemic updates the 2006 plan and provides a common national framework for coordinated multisectoral preparation and response to intensified seasonal influenza or a pandemic. Its overarching purpose is to reduce health, social and economic impacts through timely planning, prevention, detection, mitigation and recovery measures.[1][2][3]

• Strengthen preparedness across federal, state, local, community, institutional and individual levels, recognising that a pandemic may emerge anywhere and that planning assumptions must be adaptable to a novel virus.[4][5]
• Organise action through five core components: planning and coordination; monitoring and situation assessment; reduction of disease spread; continuity of health and other essential services; and communication.[6][7]
• Apply five lines of action covering preparation and dissemination, surveillance and detection, strategic reserves, response and mitigation, and research and development.[8][9]
• Prevent transmission and severe outcomes through seasonal and pandemic vaccination where available, antiviral medicines, hygiene measures, risk communication, early care-seeking and protection of health personnel.[10][11][2]
• Maintain surveillance of human influenza and relevant animal populations, including domestic and wild birds and pigs, to support early recognition of unusual events, laboratory diagnosis and assessment of transmission risks.[8][12]
• Use the World Health Organization six-phase framework as a planning tool, distinguishing preparation in phases 1 to 3 from response and mitigation in phases 4 to 6, followed by post-peak and post-pandemic recovery.[13][14]
• Promote ethical decision-making based on equity, utility or efficiency, liberty, reciprocity and solidarity, while protecting human rights and considering vulnerable groups and minorities.[15]

Implementation

Implementation relies on federal leadership, structured coordination across levels of government and sectors, and operational plans that translate national guidance into local preparedness, continuity and response arrangements. The federal government leads overall communication and coordination, while health services generate the epidemiological, clinical and virological information needed to guide measures and assess their effects.[1][16]

• Coordinate governance through the General Health Council, the National Committee for Health Security, the National Influenza Commission and national, state and jurisdictional operational structures. The National Committee for Health Security analyses, coordinates, follows up and evaluates health-security policies, while operational commands consolidate information and issue emergency reports.[17][18]
• Require state, local and sectoral bodies to prepare or update response and continuity plans, appoint coordinators, identify key personnel and critical functions, establish emergency communication channels, and test arrangements through exercises.[7][19]
• Engage public and private health services, other government sectors, businesses, civil-society and religious organisations, families and individuals in maintaining essential operations, distributing resources, supporting home care and applying hygiene and protective measures.[16][20]
• Operate surveillance through the National Epidemiological Surveillance System, including general surveillance across 19,000 health establishments, a national laboratory network and 636 sentinel Influenza Monitoring Health Units. Sentinel sampling supports identification of circulating variants and epidemiological changes without requiring testing of every influenza-like illness case.[21]
• Strengthen early warning through immediate reporting by clinicians and laboratory staff, training for primary-care and laboratory personnel, real-time polymerase chain reaction diagnostic capacity, and monitoring of viral mutations associated with antiviral resistance.[22]
• Coordinate internationally with the World Health Organization under the International Health Regulations, including consultation and notification when a novel or animal-origin influenza virus with community transmission is suspected or confirmed.[13][23]
• Prepare health services to manage surges by simplifying triage, designating treatment and isolation areas, postponing non-essential procedures, expanding critical-care capacity, training specialist staff and deploying support brigades when states require assistance.[24][25]
• Maintain strategic reserves of antivirals, antibiotics, vaccines, reagents, protective equipment and other supplies at federal, state and jurisdictional levels, with allocation protocols for scarce resources and arrangements for storage, receipt and distribution.[26][12][27]
• Protect health workers through communication, protective and disinfection materials, vaccination, dedicated care arrangements where appropriate, and continuity planning for workforce availability.[10][26]
• Deliver risk communication through consistent public, media and health-worker information, pre-established reporting formats, spokesperson networks, websites and other electronic channels. Communication is intended to reduce rumours, support informed decisions and preserve trust during changing phases of an emergency.[28][10][8]
• Support research and domestic capability by strengthening collaboration among decision-makers, academia and clinical services on diagnostics, vaccines, medicines, antivirals and epidemiological research, including efforts to reduce dependence on external technology markets.[11][9]
• Monitor implementation through surveillance, notification, reports from state structures, exercises, inventories, supply verification, assessment of response operations and review of lessons learnt. The supplied material does not specify a consolidated national set of quantitative indicators, targets or budget allocations.[29][27][30]

Monitoring & Evaluation

Mexico’s influenza-pandemic framework combines epidemiological, clinical and virological surveillance with national and subnational coordination, international notification, operational reporting and periodic review. It uses the World Health Organization (WHO) phase framework as a planning tool, rather than a prediction of severity, and maintains surveillance through post-peak and post-pandemic periods.[13][14][31]

• Strengthen general surveillance through the National Epidemiological Surveillance System, which covers 114 diseases across 19,000 health establishments, alongside specialised laboratory-network surveillance and 636 sentinel Influenza Monitoring Health Units.[21]
• Use sentinel sampling to identify circulating variants and changes in epidemiology, recognising that universal laboratory confirmation of influenza-like illness is technically and economically unfeasible.[21][22]
• Detect unusual clinical and laboratory signals, including unexpected illness in adults, negative or unsubtypable influenza tests, fever above 38°C, respiratory difficulty and oxygen saturation below 90%.[5][21]
• Require immediate reporting of unusual observations by clinicians and laboratory personnel through formal fast-track channels to a competent authority, supplemented by professional information networks.[22]
• Monitor viral isolates for mutations associated with antiviral resistance; by 28 June 2010, Mexico had identified one virus with an oseltamivir-resistance-associated mutation among 738 samples analysed.[22][32]
• Use epidemiological, clinical and virological information to assess transmission, morbidity, mortality and intervention effectiveness, and notify events involving a new human influenza virus under the International Health Regulations.[16][13]

Surveillance arrangements extend to human, domestic-animal and wildlife populations. Planned activities include influenza monitoring in birds and pigs, assessment of human-transmission risks, notification to FluNet, laboratory-method validation, identification of circulating serotypes and exchange of national and international epidemiological information.[8][12][27]

• Provide standardised daily epidemiological information at a consistent time, using agreed reporting formats to improve comparability between health institutions.[28][10]
• Maintain shared databases and electronic platforms to support inter-institutional information exchange, reduce duplicate data entry, provide updated information and monitor learning among health personnel.[10]
• Issue epidemiological alerts promptly to federal entities and maintain communication and notification channels across the national surveillance network.[12]
• Consolidate and issue emergency reports through the National Operational Command for Health Security, while state operational commands report implementation and results to state and federal levels.[18]

Accountability is principally institutional. The National Committee for Health Security analyses, coordinates, follows up and evaluates health-security policies and actions, with a Technical Subcommittee for Monitoring and Evaluation; the General Health Council is responsible for ensuring compliance with actions established in the National Plan.[17][18][33]The Committee Nacional para la Seguridad en Salud also issues Mexico’s alert-phase declarations in line with the WHO framework.[34]

Evaluation mechanisms include self-assessment annexes, practical preparedness exercises, simulations, review of liaison-point arrangements, assessment of plan dissemination and local implementation, evaluation of educational materials and media impact, inventory reviews, supply verification and assessment of rapid-response and care-centre operations.[4][29][27][25][7]The Sentinel Shield exercise in 2006 assessed national pandemic-response capacity and involved nearly 3,000 participants from Mexico City, Hidalgo, Tabasco and Chihuahua.[35]

Important evidence limitations are recognised. Confirmed 2009 pandemic cases reflected testing under health-service sampling criteria, while mild, asymptomatic, untreated and unregistered infections meant that total infection levels remained uncertain.[36]The material does not specify a consolidated national indicator set, numerical targets, uniform reporting timetable, reporting templates, independent audit mechanism or broader formal accountability framework.[13][18][29][30]

Costing & Financing

The framework identifies substantial resource needs for influenza preparedness and response, but does not provide a comprehensive implementation budget, financing plan, funding-source schedule, quantified funding gap or economic assumptions. Governments are expected to provide preparedness resources, while other sectors should plan resource distribution and continuity of essential operations.[16][20]

• Maintain and expand strategic reserves of antivirals, antibiotics, vaccines, reagents, protective equipment and other medical supplies at federal, state and jurisdictional levels.[26][12][27]
• Invest continuously in diagnostic and reference laboratories, real-time polymerase chain reaction capacity, biosafety, human resources, research and development, and training for health professionals and the media.[22][32][10]
• Strengthen hospital surge capacity through specialised personnel, intensive-care beds, mechanical ventilators, referral and isolation centres, triage arrangements, staff protection and service restructuring.[24][26][25]
• Develop domestic vaccine-production capacity, acquire and distribute pandemic-strain vaccine when available, and reduce dependence on external markets for prevention, diagnosis and treatment technologies.[11][27]
• Mobilise resources with congressional support and coordinate federal and state reserves, storage, receipt and distribution arrangements, including reporting of consumption and unmet needs.[8][27][25]

The material records a substantial post-pandemic investment in the diagnostic laboratory network, but gives no amount or funding source.[22]It also anticipates potential shortages of vaccines, medicines, medical supplies and personnel during a pandemic, reinforcing the rationale for reserves, continuity planning and additional capacity.[7][19]

Available economic evidence is limited and partly contextual. Seasonal influenza in the United States was estimated to generate approximately 10 billion US dollars in annual medical costs and nearly 90 billion US dollars in total annual economic impact.[37]A future severe pandemic was anticipated to entail direct and indirect costs amounting to hundreds of thousands of millions of Mexican pesos, without a precise estimate.[38]

The 2009 influenza A (H1N1) pandemic was estimated to cost Mexico the equivalent of 1% of its 2008 gross domestic product, described as just over 9 billion United States dollars.[39]Historical table estimates also recorded gross domestic product changes associated with the 1918-1919 Spanish influenza and the 1968-1969 Hong Kong influenza, but no economic-loss estimate was available in that table for the 2009-2010 H1N1 pandemic.[40]